Physician profile
Kirk Vance Mitchell
NPI 1811242605
$22,767.48
in general payments reported to CMS, 2019-2025
12 companies · $8,455 in 2025
The $8,455 reported for 2025 was more than what 94% of Surgery providers received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $203 · 2020: $255 · 2022: $1,048 · 2023: $261 · 2024: $13K · 2025: $8,455.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $16K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $4,000 · Food and Beverage: $1,261.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $16,000.00 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $4,000.00 |
| Food and Beverage | $1,261.06 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $22,316.68 | 2019-2025 | Da Vinci Surgical System, Davinci Xi |
| Vantive US Healthcare LLC | $136.36 | 2025 | Renal - Pd |
| Takeda Pharmaceuticals U.S.A., INC. | $125.00 | 2020 | |
| Pacira Pharmaceuticals Incorporated | $33.13 | 2024 | Exparel |
| W. L. Gore & Associates, INC. | $29.35 | 2023 | Seamguard |
| Smith+Nephew, INC. | $26.29 | 2024 | Stravix |
| Boston Scientific Corporation | $25.33 | 2023 | Rezum Generator |
| Aroa Biosurgery Incorporated | $20.99 | 2023 | |
| Dilon Technologies, INC. | $19.87 | 2023 | Hemoblast Bellows |
| Medtronic, INC. | $18.81 | 2025 | Signia |
| Conmed Corporation | $15.67 | 2023 | Airseal |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kirk Mitchell listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.